Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZT002 (Zovaglutide) Phase 1d/2a in T2DM
NCT07065032Phase 2Completed
- Sponsor
- QL Biopharm
- Start
- Feb 2024
- Primary completion
- Jul 2024
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of zovaglutide in type 2 diabetes mellitus (T2DM), sponsored by QL Biopharm. Started Feb 2024; status: completed.
02
Drugs
zovaglutide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT07065032.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07065032.